Ranked #6,737 of 8,699 institutional investors
Knott David M Jr
Syosset, NY
$168M
US stock portfolio at live prices · today −$1.7M (−1.01%)
Market closed. Prices as of Nov 20, 7:11 AM ET
- Value at quarter end (Q3 2026)
- $183M
- Change from Q2 2026
- −$6.3M (−3.35%)
- Positions
- 73 · 7 new, 11 sold out
- Filed
- Nov 12, 2026
Not counted in the ranking: none$15.2M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesAPO 15.5%GOOG 14.7%XERS 9.90%IOVA 5.06%BBIO 4.64%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| APO Apollo Global Management, Inc. | 225,000 | $26.2M | 15.5% | Unchanged |
| GOOG Alphabet Inc. | 91,420 | $24.8M | 14.7% | Unchanged |
| XERS Xeris Biopharma Holdings, Inc. | 1,002,900 | $16.7M | 9.90% | Reduced −5% |
| IOVA Iovance Biotherapeutics, Inc. | 1,165,000 | $8.5M | 5.06% | Reduced −27% |
| BBIO BridgeBio Pharma, Inc. | 100,000 | $7.8M | 4.64% | Added +8% |
| TVTX Travere Therapeutics, Inc. | 129,967 | $6.3M | 3.73% | Reduced −12% |
| VRDN Viridian Therapeutics, Inc. | 191,000 | $6.0M | 3.57% | Added +6% |
| JPM JPMorgan Chase & Co. | 17,409 | $5.6M | 3.31% | Reduced −4% |
| JAAA Janus Henderson AAA CLO ETF | 93,528 | $4.7M | 2.81% | Unchanged |
| PTGX Protagonist Therapeutics, Inc. | 32,723 | $4.1M | 2.41% | Reduced −48% |
| SNDX Syndax Pharmaceuticals, Inc. | 428,294 | $3.9M | 2.32% | Reduced −2% |
| TGTX TG Therapeutics, Inc. | 59,839 | $3.9M | 2.31% | Reduced −10% |
| COGT Cogent Biosciences, Inc. | 136,081 | $3.8M | 2.24% | Added +23% |
| OBIO Orchestra BioMed Holdings, Inc. | 253,651 | $1.8M | 1.05% | Unchanged |
| CDNA CareDx, Inc. | 22,165 | $1.6M | 0.95% | Added +63% |
| XBI State Street SPDR S&P Biotech ETF | 11,000 | $1.6M | 0.94% | Reduced −27% |
| RCUS Arcus Biosciences, Inc. | 100,241 | $1.6M | 0.94% | Added +23% |
| AB AllianceBernstein Holding L.P. | 48,000 | $1.5M | 0.90% | Unchanged |
| RLMD Relmada Therapeutics, Inc. | 480,000 | $1.5M | 0.89% | Added +6% |
| MDGL Madrigal Pharmaceuticals, Inc. | 3,600 | $1.4M | 0.85% | Added +20% |
| AGIO Agios Pharmaceuticals, Inc. | 49,058 | $1.4M | 0.84% | Reduced −48% |
| ELVN Enliven Therapeutics, Inc. | 28,904 | $1.3M | 0.80% | Added +367% |
| CLOZ Eldridge BBB-B CLO ETF | 47,807 | $1.2M | 0.74% | Unchanged |
| ORKA Oruka Therapeutics, Inc. | 11,000 | $1.1M | 0.64% | New |
| SPRB Spruce Biosciences, Inc. | 26,085 | $1.1M | 0.63% | Added +30% |
| COLL Collegium Pharmaceutical, Inc. | 39,000 | $983K | 0.58% | New |
| PFE Pfizer Inc. | 32,337 | $891K | 0.53% | Unchanged |
| AAPL Apple Inc. | 2,494 | $871K | 0.52% | Unchanged |
| CGEM Cullinan Therapeutics, Inc. | 95,369 | $865K | 0.51% | Added +38% |
| DYN Dyne Therapeutics, Inc. | 52,000 | $834K | 0.49% | New |
| MSFT Microsoft Corporation | 1,600 | $797K | 0.47% | Unchanged |
| JNJ Johnson & Johnson | 2,922 | $781K | 0.46% | Reduced −41% |
| LBRX LB Pharmaceuticals Inc | 17,065 | $683K | 0.41% | Added +32% |
| RZLT Rezolute, Inc. | 159,638 | $670K | 0.40% | Reduced −57% |
| CNQ Canadian Natural Resources Limited | 13,918 | $622K | 0.37% | Reduced −17% |
| IBB iShares Biotechnology ETF | 2,500 | $509K | 0.30% | Reduced −55% |
| BIIB Biogen Inc. | 2,000 | $494K | 0.29% | Reduced −50% |
| IBM International Business Machines Corporation | 2,142 | $480K | 0.28% | Unchanged |
| DCGO DocGo Inc. | 2,670,850 | $458K | 0.27% | Unchanged |
| SLDB Solid Biosciences Inc. | 71,129 | $458K | 0.27% | Added +27% |
| EWTX Edgewise Therapeutics, Inc. | 10,502 | $432K | 0.26% | New |
| INSM Insmed Incorporated | 2,253 | $325K | 0.19% | Reduced −47% |
| RHP Ryman Hospitality Properties, Inc. | 2,400 | $320K | 0.19% | Unchanged |
| KMB Kimberly-Clark Corporation | 2,400 | $253K | 0.15% | Unchanged |
| AVGO Broadcom Inc. | 710 | $246K | 0.15% | Unchanged |
| MDLZ Mondelez International, Inc. | 3,000 | $197K | 0.12% | Unchanged |
| NVDA NVIDIA Corporation | 1,280 | $187K | 0.11% | Unchanged |
| MLYS Mineralys Therapeutics, Inc. | 10,000 | $142K | <0.1% | New |
| NVCT Nuvectis Pharma, Inc. | 6,777 | $134K | <0.1% | New |
| PTHS Pelthos Therapeutics Inc. | 17,644 | $123K | <0.1% | Reduced −20% |
| LEGH Legacy Housing Corporation | 4,000 | $112K | <0.1% | Unchanged |
| EBC Eastern Bankshares, Inc. | 5,000 | $108K | <0.1% | Unchanged |
| PWR Quanta Services, Inc. | 176 | $103K | <0.1% | Unchanged |
| RAIN Rain Enhancement Technologies Holdco, Inc. | 101,686 | $90K | <0.1% | Unchanged |
| IWP iShares Russell Mid-Cap Growth ETF | 695 | $85K | <0.1% | Unchanged |
| URI United Rentals, Inc. | 78 | $83K | <0.1% | Unchanged |
| GOOGL Alphabet Inc. | 300 | $82K | <0.1% | Unchanged |
| ABVX ABIVAX Société Anonyme | 1,000 | $81K | <0.1% | New |
| AMZN Amazon.com, Inc. | 300 | $77K | <0.1% | Unchanged |
| CTVA Corteva, Inc. | 8,038 | $65K | <0.1% | Unchanged |
| IVVD Invivyd, Inc. | 100,000 | $45K | <0.1% | Unchanged |
| DHR Danaher Corporation | 180 | $41K | <0.1% | Unchanged |
| DOW Dow Inc. | 1,206 | $36K | <0.1% | Unchanged |
| FSK FS KKR Capital Corp. | 2,875 | $31K | <0.1% | Unchanged |
| TMO Thermo Fisher Scientific Inc. | 45 | $31K | <0.1% | Unchanged |
| OXY Occidental Petroleum Corporation | 469 | $25K | <0.1% | Unchanged |
| BX Blackstone Inc. | 210 | $24K | <0.1% | Unchanged |
| UNH UnitedHealth Group Incorporated | 57 | $19K | <0.1% | Unchanged |
| CRM Salesforce, Inc. | 77 | $14K | <0.1% | Unchanged |
| KD Kyndryl Holdings, Inc. | 428 | $7K | <0.1% | Unchanged |
| STWD Starwood Property Trust, Inc. | 400 | $5K | <0.1% | Unchanged |
| GEHC GE HealthCare Technologies Inc. | 50 | $4K | <0.1% | Unchanged |
| WAB Westinghouse Air Brake Technologies Corporation | 6 | $2K | <0.1% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| ATRC AtriCure, Inc. | 51,400 | $2.8M |
| CLST Catalyst Bancorp, Inc. | 114,000 | $2.0M |
| VSTM Verastem, Inc. | 155,000 | $1.1M |
| ARDX Ardelyx, Inc. | 263,168 | $805K |
| VERA Vera Therapeutics, Inc. | 26,000 | $696K |
| RARE Ultragenyx Pharmaceutical Inc. | 38,069 | $656K |
| KURA Kura Oncology, Inc. | 52,767 | $388K |
| BSX Boston Scientific Corporation | 6,000 | $258K |
| QTTB Q32 Bio Inc. | 30,412 | $258K |
| BMY Bristol-Myers Squibb Company | 2,000 | $117K |
| WVE Wave Life Sciences, Inc. | 40,000 | $109K |